Literature DB >> 7264888

Kinetics of aspirin, salicylic acid, and salicyluric acid following oral administration of aspirin as a tablet and two buffered solutions.

W D Mason, N Winer.   

Abstract

Twelve fasting normal volunteers received three aspirin dosage forms in a single-dose, complete crossover study; the plasma and urine levels of aspirin, salicylic acid, and salicyluric acid were measured for 10 hr. The three dosage forms were an unbuffered tablet, an effervescent solution with 16 mEq of buffer, and an effervescent solution with 34 mEq of buffer. Significant differences in the absorption rate were observed, with the solution having 16 mEQ of buffer being fastest, the solution having 34 mEq of buffer being intermediate, and the tablet being slowest. These differences are attributed to gastric emptying rates and tablet dissolution. Urine pH and renal clearance for all three acid compounds are influenced by the buffer during the first 2 hr following dosing but not later. Area under the curve comparisons suggest that approximately 20% more aspirin reaches the general circulation intact following the tablet but that the total amount of salicylate absorbed is not different. Further studies are required to select the optimal buffer content to provide rapid absorption with minimal sodium dose and urine alkalinization.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7264888     DOI: 10.1002/jps.2600700308

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  9 in total

Review 1.  Drug interactions involving aspirin (acetylsalicylic acid) and salicylic acid.

Authors:  J O Miners
Journal:  Clin Pharmacokinet       Date:  1989-11       Impact factor: 6.447

Review 2.  Salicylate intoxication in the elderly. Recognition and recommendations on how to prevent it.

Authors:  C Durnas; B J Cusack
Journal:  Drugs Aging       Date:  1992 Jan-Feb       Impact factor: 3.923

3.  The pharmacokinetics of aspirin in rats and the effect of buffer.

Authors:  C J Fu; S Melethil; W D Mason
Journal:  J Pharmacokinet Biopharm       Date:  1991-04

Review 4.  Classical absorption theory and the development of gastric mucosal damage associated with the non-steroidal anti-inflammatory drugs.

Authors:  K McCormack; K Brune
Journal:  Arch Toxicol       Date:  1987-06       Impact factor: 5.153

5.  Plasma levels of acetylsalicylic acid and salicylic acid after oral ingestion of plain and buffered acetylsalicylic acid in relation to bleeding time and thrombocyte function.

Authors:  J H Proost; G W Van Imhoff; H Wesseling
Journal:  Pharm Weekbl Sci       Date:  1983-02-25

6.  Platelet aggregation and plasma levels of acetylsalicylic acid in stroke patients on long-term treatment with an enteric-coated aspirin formulation.

Authors:  M Britton; A Melander; J Svensson; E Wåhlin-Boll
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

Review 7.  Enhancement of drug absorption by antacids. An unrecognised drug interaction.

Authors:  P J Neuvonen; K T Kivistö
Journal:  Clin Pharmacokinet       Date:  1994-08       Impact factor: 6.447

Review 8.  Clinical pharmacokinetics of the salicylates.

Authors:  C J Needs; P M Brooks
Journal:  Clin Pharmacokinet       Date:  1985 Mar-Apr       Impact factor: 6.447

9.  Pharmacokinetics and plasma concentrations of acetylsalicylic acid after intravenous, rectal, and intragastric administration to horses.

Authors:  Ted A Broome; Murray P Brown; Ronald R Gronwall; Matthew F Casey; Kelly A Meritt
Journal:  Can J Vet Res       Date:  2003-10       Impact factor: 1.310

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.